QC Ware and IonQ Achieve Chemical Accuracy in Hybrid Quantum Chemistry Workflow for Drug Discovery - Quantum Computing Report

Skip to content

GQINewsNews Archive 2026News Archive 2025News Archive 2024News Archive 2023News Archive 2022News Archive 2021News Archive 2020News Archive 2019News Archive 2018News Archive 2015-2017AnalysisQnalysisPlayersPublic CompaniesPrivate/Startup CompaniesUniversitiesGovernment/Non-ProfitVenture CapitalVenture Capital – Sorted by Quantum CompanyResourcesConferencesToolsOther Websites and Industry AssociationsEducationBooksScorecardsGate Level Software PlatformsIBM Qiskit, Rigetti Forest, Microsoft QDK, Project QReview of the Cirq Quantum Software FrameworkQubit Implementation DashboardQubit CountQubit QualityQubit TechnologySoftware/Startup PartnersCloud Platform Hardware PartnersPodcastsAboutQCR Alerts Sign-Up FormAdvertising InquiriesQCR in the NewsContactPrivacy PolicyMembership

QC Ware and IonQ Achieve Chemical Accuracy in Hybrid Quantum Chemistry Workflow for Drug Discovery

Quantum software developer QC Ware and trapped-ion hardware vendor IonQ (NYSE: IONQ) have demonstrated a hybrid quantum-classical chemistry workflow combining QC Ware’s Promethium® platform with the IonQ Forte quantum computer. Executed via Amazon Braket and supported by AWS cloud compute credits, the joint test calculated electrostatic interaction energy within 0.5 kcal/mol (~4%) of classical benchmarks—clearing the 1 kcal/mol threshold required for true chemical accuracy in enzyme active-site modeling.